##INFO=<ID=MP,Number=1,Type=Double,Description="Mutation priority">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Allele count in genotypes, for each ALT allele, in the same order as listed">
##INFO=<ID=AF,Number=A,Type=Float,Description="Allele Frequency, for each ALT allele, in the same order as listed">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=BaseQRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of Alt Vs. Ref base qualities">
##INFO=<ID=ClippingRankSum,Number=1,Type=Float,Description="Z-score From Wilcoxon rank sum test of Alt vs. Ref number of hard clipped bases">
##INFO=<ID=DP,Number=1,Type=Integer,Description="Approximate read depth; some reads may have been filtered">
##INFO=<ID=DS,Number=0,Type=Flag,Description="Were any of the samples downsampled?">
##INFO=<ID=END,Number=1,Type=Integer,Description="Stop position of the interval">
##INFO=<ID=ExcessHet,Number=1,Type=Float,Description="Phred-scaled p-value for exact test of excess heterozygosity">
##INFO=<ID=FS,Number=1,Type=Float,Description="Phred-scaled p-value using Fisher's exact test to detect strand bias">
##INFO=<ID=HaplotypeScore,Number=1,Type=Float,Description="Consistency of the site with at most two segregating haplotypes">
##INFO=<ID=InbreedingCoeff,Number=1,Type=Float,Description="Inbreeding coefficient as estimated from the genotype likelihoods per-sample when compared against the Hardy-Weinberg expectation">
##INFO=<ID=MLEAC,Number=A,Type=Integer,Description="Maximum likelihood expectation (MLE) for the allele counts (not necessarily the same as the AC), for each ALT allele, in the same order as listed">
##INFO=<ID=MLEAF,Number=A,Type=Float,Description="Maximum likelihood expectation (MLE) for the allele frequency (not necessarily the same as the AF), for each ALT allele, in the same order as listed">
##INFO=<ID=MQ,Number=1,Type=Float,Description="RMS Mapping Quality">
##INFO=<ID=MQRankSum,Number=1,Type=Float,Description="Z-score From Wilcoxon rank sum test of Alt vs. Ref read mapping qualities">
##INFO=<ID=NEGATIVE_TRAIN_SITE,Number=0,Type=Flag,Description="This variant was used to build the negative training set of bad variants">
##INFO=<ID=PG,Number=G,Type=Integer,Description="Genotype Likelihood Prior">
##INFO=<ID=POSITIVE_TRAIN_SITE,Number=0,Type=Flag,Description="This variant was used to build the positive training set of good variants">
##INFO=<ID=QD,Number=1,Type=Float,Description="Variant Confidence/Quality by Depth">
##INFO=<ID=RAW_MQ,Number=1,Type=Float,Description="Raw data for RMS Mapping Quality">
##INFO=<ID=ReadPosRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of Alt vs. Ref read position bias">
##INFO=<ID=SOR,Number=1,Type=Float,Description="Symmetric Odds Ratio of 2x2 contingency table to detect strand bias">
##INFO=<ID=VQSLOD,Number=1,Type=Float,Description="Log odds of being a true variant versus being false under the trained gaussian mixture model">
##INFO=<ID=culprit,Number=1,Type=String,Description="The annotation which was the worst performing in the Gaussian mixture model, likely the reason why the variant was filtered out">
##INFO=<ID=CLNSIG,Number=.,Type=String,Description="Variant Clinical Significance, 0 - Uncertain significance, 1 - not provided, 2 - Benign, 3 - Likely benign, 4 - Likely pathogenic, 5 - Pathogenic, 6 - drug response, 7 - histocompatibility, 255 - other">
##INFO=<ID=CLNREVSTAT,Number=.,Type=String,Description="no_assertion - No assertion provided, no_criteria - No assertion criteria provided, single - Criteria provided single submitter, mult - Criteria provided multiple submitters no conflicts, conf - Criteria provided conflicting interpretations, exp - Reviewed by expert panel, guideline - Practice guideline">
##INFO=<ID=CLNDBN,Number=.,Type=String,Description="Variant disease name">
##INFO=<ID=OM,Number=0,Type=Flag,Description="Has OMIM/OMIA">
##INFO=<ID=PM,Number=0,Type=Flag,Description="Variant is Precious(Clinical,Pubmed Cited)">
##INFO=<ID=X1000Gp3_AF,Number=A,Type=Float,Description="Estimated allele frequency in the range (0,1]">
##INFO=<ID=ExAC_AF,Number=A,Type=Float,Description="Allele Frequency, for each ALT allele, in the same order as listed">
##INFO=<ID=ESP6500_AF,Number=.,Type=String,Description="Minor Allele Frequency in percent in the order of EA,AA,All">
##INFO=<ID=BIOBANK_AF_v20171101,Number=A,Type=Float,Description="Allele Frequency in the SPBU BIOBANK (collected 2017-11-01 (570 samples)">
##INFO=<ID=GWASCAT_TRAIT,Number=.,Type=String,Description="GWAS catalog: Associated trait">
##INFO=<ID=GWASCAT_P_VALUE,Number=.,Type=Float,Description="GWAS catalog: p-value">
##INFO=<ID=GWASCAT_OR_BETA,Number=.,Type=Float,Description="GWAS catalog: OR or Beta">
##INFO=<ID=GWASCAT_REPORTED_GENE,Number=.,Type=String,Description="GWAS catalog: Reported gene">
##INFO=<ID=GWASCAT_PUBMED_ID,Number=.,Type=String,Description="GWAS catalog: Original paper's Pubmed ID">
##INFO=<ID=dbNSFP_Polyphen2_HVAR_pred,Number=A,Type=Character,Description="Field 'Polyphen2_HVAR_pred' from dbNSFP">
##INFO=<ID=dbNSFP_PROVEAN_pred,Number=A,Type=Character,Description="Field 'PROVEAN_pred' from dbNSFP">
##INFO=<ID=dbNSFP_SIFT_pred,Number=A,Type=Character,Description="Field 'SIFT_pred' from dbNSFP">
##INFO=<ID=ANN,Number=.,Type=String,Description="Functional annotations: 'Allele | Annotation | Annotation_Impact | Gene_Name | Gene_ID | Feature_Type | Feature_ID | Transcript_BioType | Rank | HGVS.c | HGVS.p | cDNA.pos / cDNA.length | CDS.pos / CDS.length | AA.pos / AA.length | Distance | ERRORS / WARNINGS / INFO' ">
##INFO=<ID=LOF,Number=.,Type=String,Description="Predicted loss of function effects for this variant. Format: 'Gene_Name | Gene_ID | Number_of_transcripts_in_gene | Percent_of_transcripts_affected' ">
##INFO=<ID=NMD,Number=.,Type=String,Description="Predicted nonsense mediated decay effects for this variant. Format: 'Gene_Name | Gene_ID | Number_of_transcripts_in_gene | Percent_of_transcripts_affected' ">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	SB0-0005	SB1-0020	SB1-0327	SB4-0004	SB4-0022	SB4-0032	SSMA2	SSMA3
1	115222237	rs34526199	T	A	42754.72	PASS	CLNDBN=Muscle_AMP_deaminase_deficiency;MP=3.0;MQ=60.0;CLNSIG=5;AF=0.063;ExAC_AF=0.028;PM;X1000Gp3_AF=;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=DD|;BIOBANK_AF_v20171101=0.056;QD=11.61;VQSLOD=12.25;ESP6500_AF=0.0241427;dbNSFP_PROVEAN_pred=DD|D|;CLNREVSTAT=single;dbNSFP_SIFT_pred=DD|D|;
1	145507765	rs201779890	G	C	2001.97	PASS	CLNDBN=Radial_aplasia-thrombocytopenia_syndromenot_provided|;MP=7.0;MQ=59.97;CLNSIG=5255|;AF=0.125;OM;PM;X1000Gp3_AF=;ExAC_AF=0.005349;FS=1.815;BIOBANK_AF_v20171101=0.017;QD=10.71;VQSLOD=1.78;ESP6500_AF=0.00492081;CLNREVSTAT=singleconf|;
1	159175494	rs34599082	C	T	3912.16	PASS	CLNDBN=DUFFY_BLOOD_GROUP_SYSTEM\x2c_FY(bwk)_PHENOTYPE;MP=3.0;MQ=60.0;CLNSIG=5;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.011;FS=0.409;dbNSFP_Polyphen2_HVAR_pred=PP|;BIOBANK_AF_v20171101=0.029;QD=12.3;VQSLOD=10.04;ESP6500_AF=0.0109949;dbNSFP_PROVEAN_pred=NN|N|N|N|;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=TT|T|T|T|;
1	227170648	rs41303129	C	T	6661.16	PASS	CLNDBN=Coenzyme_Q10_deficiency\x2c_primary\x2c_4not_specified|Spinocerebellar_Ataxia\x2c_Recessive|not_provided|;MP=3.0;MQ=60.0;CLNSIG=52|3|0|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.016;FS=1.104;BIOBANK_AF_v20171101=0.011;QD=10.2;VQSLOD=11.44;ESP6500_AF=0.0150046;CLNREVSTAT=no_criteriamult|single|single|;
2	25457242	rs147001633	C	T	168.18	PASS	CLNDBN=Acute_myeloid_leukemiaAdenocarcinoma_of_lung|Myelodysplastic_syndrome|Acute_myeloid_leukemia|Adenocarcinoma_of_lung|Acute_myeloid_leukemia|Myelodysplastic_syndrome|not_provided|;MP=9.0;MQ=60.0;CLNSIG=54|4|5|4|5|4|5|;AF=0.063;ExAC_AF=5.93E-4;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=BB|;QD=2.16;VQSLOD=10.71;ESP6500_AF=0.000691988;dbNSFP_PROVEAN_pred=DD|D|D|;CLNREVSTAT=no_criteriano_criteria|no_criteria|no_criteria|no_criteria|no_criteria|no_criteria|single|;dbNSFP_SIFT_pred=DD|D|D|;
2	48025764	rs1800937	C	T	28508.55	PASS	CLNDBN=Lynch_syndromeLynch_syndrome|not_provided|Lynch_syndrome|not_specified|Hereditary_cancer-predisposing_syndrome|;MP=3.0;MQ=59.99;CLNSIG=55|5|2|2|2|;AF=0.25;ExAC_AF=0.072;PM;X1000Gp3_AF=;FS=1.794;BIOBANK_AF_v20171101=0.109;QD=13.6;VQSLOD=5.05;ESP6500_AF=0.0691219;CLNREVSTAT=expexp|single|exp|mult|mult|;
2	71337204	rs138436961	G	A	7562.82	PASS	CLNDBN=Methylmalonyl-CoA_epimerase_deficiency;MP=9.0;MQ=60.0;CLNSIG=5;AF=0.125;ExAC_AF=0.005247;FS=1.745;dbNSFP_Polyphen2_HVAR_pred=D;BIOBANK_AF_v20171101=0.005703;QD=9.78;VQSLOD=6.44;ESP6500_AF=0.00538213;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteria;X1000Gp3_AF=9.98403E-4;dbNSFP_SIFT_pred=DD|;
2	233390199	rs61744404	C	G	9600.42	PASS	BIOBANK_AF_v20171101=0.048;QD=14.22;CLNDBN=Microphthalmia\x2c_isolated_6not_specified|;MP=3.0;MQ=59.91;VQSLOD=1.76;CLNSIG=52|;AF=0.188;OM;PM;X1000Gp3_AF=;CLNREVSTAT=no_criteriasingle|;ExAC_AF=0.037;FS=0.0;
2	238242176	rs182976977	G	C	577.18	PASS	CLNDBN=Dystonia_27not_specified|Collagen_VI-related_myopathy|;MP=7.0;MQ=60.0;CLNSIG=53|3|;AF=0.063;ExAC_AF=9.719E-4;PM;X1000Gp3_AF=;FS=2.021;dbNSFP_Polyphen2_HVAR_pred=BB|B|;QD=8.75;VQSLOD=5.19;ESP6500_AF=0.000615101;dbNSFP_PROVEAN_pred=NN|N|N|N|N|;CLNREVSTAT=no_criteriamult|single|;dbNSFP_SIFT_pred=DD|D|T|D|D|;
3	39307162	rs3732378	G	A	21284.51	PASS	CLNDBN=Human_immunodeficiency_virus_type_1\x2c_rapid_progression_to_AIDSCoronary_artery_disease\x2c_resistance_to|Age-related_macular_degeneration_12|MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_12\x2c_SUSCEPTIBILITY_TO|;MP=3.0;MQ=60.0;CLNSIG=5255|255|255|;AF=0.125;OM;PM;X1000Gp3_AF=;ExAC_AF=0.136;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=B;BIOBANK_AF_v20171101=0.209;QD=13.38;VQSLOD=14.22;ESP6500_AF=0.127371;dbNSFP_PROVEAN_pred=DD|D|D|D|;CLNREVSTAT=no_criteriano_criteria|no_criteria|no_criteria|;dbNSFP_SIFT_pred=DD|T|D|D|;
3	39307256	rs3732379	C	T	54565.36	PASS	CLNDBN=Human_immunodeficiency_virus_type_1\x2c_rapid_progression_to_AIDSCoronary_artery_disease\x2c_resistance_to|Age-related_macular_degeneration_12|MACULAR_DEGENERATION\x2c_AGE-RELATED\x2c_12\x2c_SUSCEPTIBILITY_TO|;MP=3.0;MQ=60.0;CLNSIG=5255|255|255|;AF=0.125;OM;PM;X1000Gp3_AF=;ExAC_AF=0.221;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=B;BIOBANK_AF_v20171101=0.277;QD=13.49;VQSLOD=14.0;ESP6500_AF=0.231074;dbNSFP_PROVEAN_pred=NN|N|N|N|;CLNREVSTAT=no_criteriano_criteria|no_criteria|no_criteria|;dbNSFP_SIFT_pred=TT|T|T|T|;
3	132408107	rs751527253	C	C	1465.13	PASS	ANN=Csplice_acceptor_variant&intron_variant|HIGH|NPHP3-ACAD11|NPHP3-ACAD11|transcript|NR_037804|pseudogene|18/44|n.2700-2_2700-1delAG|||||||C|splice_acceptor_variant&intron_variant|HIGH|NPHP3|NPHP3|transcript|NM_153240|protein_coding|19/26|c.2694-2_2694-1delAG|||||||;QD=19.8;CLNDBN=Meckel_syndrome_type_7Renal-hepatic-pancreatic_dysplasia|Nephronophthisis|Polycystic_kidney_dysplasia|not_provided|;MP=9.0;MQ=60.43;VQSLOD=1.57;CLNSIG=55|5|5|5|;PM;ExAC_AF=;AF=0.063;ESP6500_AF=0.000239655;CLNREVSTAT=no_criteriano_criteria|single|no_criteria|single|;FS=0.883;
3	148895654	rs34394958	A	G	31140.02	PASS	CLNDBN=Deficiency_of_ferroxidasenot_specified|Deficiency_of_ferroxidase|Hermansky-Pudlak_syndrome|;MP=3.0;MQ=60.0;CLNSIG=52|3|3|;AF=0.125;ExAC_AF=0.033;PM;X1000Gp3_AF=;FS=0.523;BIOBANK_AF_v20171101=0.036;QD=13.19;VQSLOD=11.7;ESP6500_AF=0.031447;CLNREVSTAT=no_criteriasingle|single|single|;
3	151055867	rs121917885	C	T	498.18	PASS	CLNDBN=Platelet-type_bleeding_disorder_8;MP=3.0;MQ=60.0;CLNSIG=5;AF=0.063;OM;PM;ExAC_AF=;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=D;QD=6.31;VQSLOD=4.86;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=DD|;
3	165547569	rs28933390	C	A	2325.73	PASS	CLNDBN=BCHE\x2c_fluoride_2Deficiency_of_butyrylcholine_esterase|;MP=7.0;MQ=60.0;CLNSIG=5255|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.003015;FS=2.279;dbNSFP_Polyphen2_HVAR_pred=B;BIOBANK_AF_v20171101=0.006641;QD=10.34;VQSLOD=5.32;ESP6500_AF=0.00361372;dbNSFP_PROVEAN_pred=N;CLNREVSTAT=no_criteriaconf|;dbNSFP_SIFT_pred=D;
5	1272311	rs141425941	C	T	891.18	PASS	CLNDBN=Pulmonary_fibrosis_and/or_bone_marrow_failure\x2c_telomere-related\x2c_1Dyskeratosis_congenita\x2c_autosomal_dominant\x2c_2|Idiopathic_fibrosing_alveolitis\x2c_chronic_form|;MP=5.0;MQ=60.0;CLNSIG=50|0|;PM;ExAC_AF=;AF=0.063;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=BP|;QD=11.43;VQSLOD=4.76;ESP6500_AF=0.000240308;dbNSFP_PROVEAN_pred=NN|;CLNREVSTAT=no_criteriasingle|single|;dbNSFP_SIFT_pred=TT|;
5	41862758	rs75134564	G	A	1221.18	PASS	CLNDBN=Succinyl-CoA_acetoacetate_transferase_deficiency;MP=7.0;MQ=60.0;CLNSIG=5;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.001334;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=P;BIOBANK_AF_v20171101=9.524E-4;QD=12.72;VQSLOD=5.85;ESP6500_AF=7.68876e-05;dbNSFP_PROVEAN_pred=N;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=D;
6	157519969	rs748363079	T	C	488.18	PASS	QD=5.88;CLNDBN=Coffin-Siris_syndrome_1;MP=3.0;MQ=60.0;VQSLOD=7.73;CLNSIG=5;PM;ExAC_AF=;AF=0.063;CLNREVSTAT=no_criteria;FS=0.0;
1	28228553	rs74653330	C	T	18183.82	PASS	CLNDBN=Tyrosinase-positive_oculocutaneous_albinismnot_specified|not_provided|;MP=7.0;MQ=60.0;CLNSIG=53|0|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.00775;FS=4.082;dbNSFP_Polyphen2_HVAR_pred=PP|;BIOBANK_AF_v20171101=0.018;QD=11.69;VQSLOD=6.58;ESP6500_AF=0.00130709;dbNSFP_PROVEAN_pred=NN|D|;CLNREVSTAT=no_criteriamult|single|;dbNSFP_SIFT_pred=TT|T|;
1	80472526	rs11555096	C	T	18199.02	PASS	CLNDBN=Fumarylacetoacetase_pseudodeficiencyTyrosinemia_type_I|not_provided|;MP=3.0;MQ=60.0;CLNSIG=55|255|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.017;FS=1.088;dbNSFP_Polyphen2_HVAR_pred=D;BIOBANK_AF_v20171101=0.047;QD=11.69;VQSLOD=12.74;ESP6500_AF=0.0163002;dbNSFP_PROVEAN_pred=DD|D|;CLNREVSTAT=no_criteriano_criteria|single|;dbNSFP_SIFT_pred=DD|D|;
1	2168022	rs199476099	C	A	5772.61	PASS	CLNDBN=Polycystic_kidney_disease\x2c_adult_type;MP=7.0;MQ=40.41;CLNSIG=5;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.002248;FS=2.472;dbNSFP_Polyphen2_HVAR_pred=BP|;BIOBANK_AF_v20171101=0.021;QD=10.67;VQSLOD=-4.142;ESP6500_AF=0.00160973;dbNSFP_PROVEAN_pred=NN|N|;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=TT|D|;
1	14041848	rs121913049	C	T	1448.57	PASS	CLNDBN=Xeroderma_pigmentosum\x2c_group_Fnot_specified|not_provided|Cockayne_syndrome|Fanconi_anemia\x2c_complementation_group_Q|Xeroderma_pigmentosum\x2c_group_F|;MP=5.0;MQ=60.0;CLNSIG=50|0|0|0|0|;AF=0.063;OM;PM;ExAC_AF=;FS=3.883;dbNSFP_Polyphen2_HVAR_pred=D;BIOBANK_AF_v20171101=0.002846;QD=9.92;VQSLOD=4.35;ESP6500_AF=0.000769586;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteriasingle|single|single|single|single|;dbNSFP_SIFT_pred=DD|;
1	66551110	rs137886900	G	A	2803.57	PASS	CLNDBN=Mitochondrial_DNA_depletion_syndrome_2Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions\x2c_autosomal_recessive_3|Mitochondrial_DNA_depletion_syndrome_2|;MP=3.0;MQ=60.0;CLNSIG=55|5|;AF=0.063;OM;PM;ExAC_AF=;FS=1.769;dbNSFP_Polyphen2_HVAR_pred=DD|D|D|D|;BIOBANK_AF_v20171101=9.56E-4;QD=14.23;VQSLOD=7.29;dbNSFP_PROVEAN_pred=DD|D|D|D|D|D|D|;CLNREVSTAT=no_criteriano_criteria|no_criteria|;dbNSFP_SIFT_pred=DD|D|D|D|D|D|D|;
1	12899902	rs5030739	C	T	12571.79	PASS	CLNDBN=Prostate_cancer\x2c_hereditary\x2c_2not_specified|Combined_oxidative_phosphorylation_deficiency_17|;MP=3.0;MQ=60.0;CLNSIG=52|2|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.034;FS=1.105;dbNSFP_Polyphen2_HVAR_pred=BB|B|B|B|B|B|B|;BIOBANK_AF_v20171101=0.03;QD=11.08;VQSLOD=13.08;ESP6500_AF=0.028756;dbNSFP_PROVEAN_pred=NN|N|N|;CLNREVSTAT=no_criteriamult|single|;dbNSFP_SIFT_pred=TT|T|T|;
1	72759575	rs119486097	G	A	5172.58	PASS	CLNDBN=Nephrolithiasis/osteoporosis\x2c_hypophosphatemic\x2c_2not_specified|;MP=5.0;MQ=60.0;CLNSIG=53|;AF=0.063;OM;PM;X1000Gp3_AF=;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=P.|;BIOBANK_AF_v20171101=0.01;QD=10.94;VQSLOD=7.4;ESP6500_AF=0.00238352;dbNSFP_PROVEAN_pred=DN|;CLNREVSTAT=no_criteriasingle|;dbNSFP_SIFT_pred=DT|;
1	57134052	rs121908253	G	A	703.18	PASS	CLNDBN=Hennekam_lymphangiectasia-lymphedema_syndrome;MP=7.0;MQ=60.0;CLNSIG=5;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=2.224E-4;FS=0.869;dbNSFP_Polyphen2_HVAR_pred=B;QD=9.25;VQSLOD=4.52;ESP6500_AF=0.000230663;dbNSFP_PROVEAN_pred=D;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=D;
1	11210912	rs2228671	C	T	46978.43	PASS	CLNDBN=Familial_hypercholesterolemiaFamilial_hypercholesterolemia|Familial_hypercholesterolemia|not_specified|;MP=3.0;MQ=60.0;CLNSIG=5255|255|2|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.086;FS=0.0;BIOBANK_AF_v20171101=0.083;QD=12.25;VQSLOD=13.74;ESP6500_AF=0.0905736;CLNREVSTAT=multconf|conf|mult|;
1	35786868	rs2301600	C	T	15890.4	PASS	CLNDBN=Spastic_paraplegia_75\x2c_autosomal_recessive;MP=3.0;MQ=59.8;CLNSIG=5;AF=0.188;ExAC_AF=0.263;PM;X1000Gp3_AF=;FS=0.534;BIOBANK_AF_v20171101=0.175;QD=13.39;VQSLOD=3.2;ESP6500_AF=0.182741;CLNREVSTAT=no_criteria;
1	45316804	rs3810141	C	T	14862.36	PASS	CLNDBN=BLOOD_GROUP--LUTHERAN_NULL;MP=3.0;MQ=60.0;CLNSIG=5;AF=0.188;OM;PM;X1000Gp3_AF=;ExAC_AF=0.086;FS=0.523;BIOBANK_AF_v20171101=0.07;QD=16.77;VQSLOD=9.05;ESP6500_AF=0.0713736;CLNREVSTAT=no_criteria;
2	5283323	rs74315416	A	C	586.18	PASS	CLNDBN=Kallmann_syndrome_3not_specified|Hypogonadism_with_anosmia|;MP=7.0;MQ=60.0;CLNSIG=53|3|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.002249;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=D;QD=7.92;VQSLOD=4.24;ESP6500_AF=0.00261418;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteriasingle|single|;dbNSFP_SIFT_pred=DD|;
2	5283323	rs74315416	A	C	586.18	PASS	CLNDBN=Kallmann_syndrome_3not_specified|Hypogonadism_with_anosmia|;MP=7.0;MQ=60.0;CLNSIG=53|3|;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.002249;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=D;QD=7.92;VQSLOD=4.24;ESP6500_AF=0.00261418;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteriasingle|single|;dbNSFP_SIFT_pred=DD|;
2	23618427	rs1064039	C	T	19026.03	PASS	CLNDBN=Age-related_macular_degeneration_11;MP=3.0;MQ=59.98;CLNSIG=5;AF=0.063;OM;PM;X1000Gp3_AF=;ExAC_AF=0.12;FS=0.571;dbNSFP_Polyphen2_HVAR_pred=B;BIOBANK_AF_v20171101=0.229;QD=12.43;VQSLOD=1.68;ESP6500_AF=0.177988;dbNSFP_PROVEAN_pred=NN|N|;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=TT|T|;
2	43280227	rs73598374	C	T	8472.7	PASS	CLNDBN=Adenosine_deaminase_2_allozymeSevere_combined_immunodeficiency_due_to_ADA_deficiency|;MP=3.0;MQ=60.0;CLNSIG=53|;AF=0.125;OM;PM;X1000Gp3_AF=;ExAC_AF=0.034;FS=0.521;dbNSFP_Polyphen2_HVAR_pred=B;BIOBANK_AF_v20171101=0.049;QD=12.02;VQSLOD=9.49;ESP6500_AF=0.0308014;dbNSFP_PROVEAN_pred=NN|;CLNREVSTAT=no_criteriasingle|;dbNSFP_SIFT_pred=TT|;
2	46931109	rs12483377	G	A	26975.46	PASS	CLNDBN=Knobloch_syndrome_1not_specified|;MP=3.0;MQ=60.23;CLNSIG=52|;AF=0.125;OM;PM;X1000Gp3_AF=;ExAC_AF=0.059;FS=0.523;dbNSFP_Polyphen2_HVAR_pred=DD|D|D|;BIOBANK_AF_v20171101=0.081;QD=11.53;VQSLOD=2.34;ESP6500_AF=0.0710223;dbNSFP_PROVEAN_pred=DD|D|D|D|D|;CLNREVSTAT=no_criteriasingle|;dbNSFP_SIFT_pred=TT|T|T|D|T|;
2	17670877	rs146597836	C	T	924.18	PASS	CLNDBN=Behcet's_syndrome;MP=9.0;MQ=60.0;CLNSIG=5;AF=0.063;ExAC_AF=0.001977;FS=3.649;dbNSFP_Polyphen2_HVAR_pred=BB|;QD=9.24;VQSLOD=5.13;ESP6500_AF=0.00161464;dbNSFP_PROVEAN_pred=NN|N|N|N|;CLNREVSTAT=no_criteria;X1000Gp3_AF=5.99042E-4;dbNSFP_SIFT_pred=TT|T|T|T|;
2	18901004	rs450046	C	T	391886.21	PASS	CLNDBN=Proline_dehydrogenase_deficiencySchizophrenia_4|not_provided|;MP=3.0;MQ=59.93;CLNSIG=5255|5|;AF=1.0;OM;PM;X1000Gp3_AF=;ExAC_AF=0.915;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=B;BIOBANK_AF_v20171101=0.912;QD=28.11;VQSLOD=1.91;ESP6500_AF=0.904201;dbNSFP_PROVEAN_pred=NN|;CLNREVSTAT=no_criteriano_criteria|no_criteria|;dbNSFP_SIFT_pred=TT|;
2	18905964	rs2904552	C	T	11385.86	PASS	NEGATIVE_TRAIN_SITE;QD=;CLNDBN=Proline_dehydrogenase_deficiencySchizophrenia_4|;MP=3.0;MQ=55.19;CLNSIG=5255|;AF=0.125;OM;PM;X1000Gp3_AF=;ExAC_AF=0.075;FS=1.12;dbNSFP_Polyphen2_HVAR_pred=BP|B|;BIOBANK_AF_v20171101=0.068;VQSLOD=-1.877;ESP6500_AF=0.0815903;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteriano_criteria|;dbNSFP_SIFT_pred=DT|;
2	24896073	rs138081800	A	G	726.18	PASS	ANN=Gsplice_acceptor_variant&intron_variant|HIGH|UPB1|UPB1|transcript|NM_016327|protein_coding|1/9|c.105-2A>G|||||||;QD=11.0;CLNDBN=Deficiency_of_beta-ureidopropionase;MP=8.0;MQ=60.0;VQSLOD=5.33;CLNSIG=5;PM;ExAC_AF=;AF=0.063;ESP6500_AF=0.000153775;CLNREVSTAT=no_criteria;FS=2.128;
2	51063477	rs6151429	T	C	1312.66	PASS	BIOBANK_AF_v20171101=0.043;QD=12.27;CLNDBN=Arylsulfatase_A_pseudodeficiencyMetachromatic_leukodystrophy|not_provided|not_specified|;MP=3.0;MQ=60.0;VQSLOD=12.48;CLNSIG=5255|255|2|;AF=0.063;OM;PM;X1000Gp3_AF=;CLNREVSTAT=no_criteriaconf|mult|single|;FS=0.726;
X	55057617	rs140772352	G	C	8342.57	PASS	QD=11.15;CLNDBN=Hereditary_sideroblastic_anemianot_specified|;MP=3.0;MQ=60.0;VQSLOD=6.81;CLNSIG=50|;AF=0.063;CLNREVSTAT=no_criteriasingle|;FS=0.0;PM;BIOBANK_AF_v20171101=;
X	105278361	rs1804495	C	A	22062.28	PASS	CLNDBN=Thyroxine-binding_globulin\x2c_variant_P;MP=3.0;MQ=60.0;CLNSIG=5;AF=0.25;OM;PM;ExAC_AF=;FS=0.0;dbNSFP_Polyphen2_HVAR_pred=P;BIOBANK_AF_v20171101=0.08;QD=17.76;VQSLOD=11.81;ESP6500_AF=0.115782;dbNSFP_PROVEAN_pred=DD|;CLNREVSTAT=no_criteria;dbNSFP_SIFT_pred=DD|;
